US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...

New UK study reveals daily physical activity reduces brain disease risk from dementia to depression, anxiety, stroke and ...

Doing the activity a few times a week has been linked to a reduced risk of serious health conditions - including heart ...

Most people will be able to include this in their day-to-day lives easily - and it doesn't have to take up much time either to make a difference ...

Moderate-to-vigorous exercise could significantly reduce the risk of developing brain-related health conditions, new research ...

Getting in a certain amount of daily moderate-to-vigorous physical activity can help lower the risk for neuropsychiatric ...

A recent study suggests that engaging in moderate to vigorous physical activity may help lower the risk of dementia, stroke, anxiety, depression, and sleep disorders.'This ...

LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...

Doctors have issued five separate health warnings to people who don't exercise regularly, saying there is a serious risk if ...

Upping your physical activity level may lower your risk of developing neuropsychiatric diseases such as anxiety, depression ...

BioArctic AB's (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia has declined the approval of lecanemab (generic name) as a ...